The American Society for Radiation Oncology (ASTRO) has selected 19 distinguished members to receive the ASTRO Fellow (FASTRO) designation. The 2020 class of Fellows will be recognized at a virtual awards ceremony on October 27 during ASTRO’s 62nd Annual Meeting.
The ASTRO Fellows program recognizes individuals who have made significant contributions to the society and to the field of radiation oncology through research, education, patient care, and service to the field. Since its inception in 2006, the FASTRO designation has been awarded to 366 of ASTRO’s more than 10,000 members worldwide.
Theodore L. DeWeese, MD, FASTRO
“On behalf of ASTRO, I commend these outstanding physicians and scientists for their collective and far-reaching contributions to our specialty, as well as for each individual’s work to advance cancer research, education, and clinical care to improve patient outcomes,” said Theodore L. DeWeese, MD, FASTRO, Chair of the ASTRO Board of Directors.
The list of the 2020 Fellows follow:
- Elizabeth H. Baldini, MD, MPH, Brigham & Women’s Hospital/Dana-Farber Cancer Institute
- Sushil Beriwal, MD, MBA, UPMC Hillman Cancer Center
- Ronald C. Chen, MD, MPH, University of Kansas Cancer Center
- Prajnan Das, MD, MS, MPH, The University of Texas MD Anderson Cancer Center
- William F. Demas, MD, Northeast Ohio Medical University, Salem Regional Medical Center
- Jason A. Efstathiou, MD, DPhil, Massachusetts General Hospital, Harvard Medical School
- Ronald D. Ennis, MD, Cancer Institute of New Jersey, Rutgers University
- Michael Hagan, MD, PhD, Virginia Commonwealth University
- Anuja Jhingran, MD, The University of Texas MD Anderson Cancer Center
- Stanley Liauw, MD, University of Chicago
- Anita Mahajan, MD, Mayo Clinic
- Mark J. Rivard, PhD, Brown University, Rhode Island Hospital
- Joseph Kamel Salama, MD, Duke University School of Medicine
- Felicia E. Snead, MD, UPMC Hillman Cancer Center
- Dian Wang, MD, PhD, Rush University Medical Center
- Julia S. Wong, MD, Brigham & Women’s Hospital/Dana-Farber Cancer Institute
- Sue S. Yom, MD, PhD, MAS, University of California San Francisco
- Ning Jeff Yue, PhD, Cancer Institute of New Jersey, Rutgers University
- Michael J. Zelefsky, MD, Memorial Sloan Kettering Cancer Center.
Fellow candidates must be nominated by a current ASTRO Fellow, accompanied by three letters of support from ASTRO members. A committee reviews all nominations and presents the candidates to ASTRO’s Board of Directors for approval.
ASTRO’s 62nd Annual Meeting will be held October 25–28 via an interactive virtual platform. The meeting, “Global Oncology: Radiation Therapy in a Changing World,” will feature more than 2,500 abstract presentations, including reports from the latest clinical trials; expert panels on COVID-19, health disparities, global oncology, and other timely topics; Cancer Breakthrough sessions with research highlights from other leading medical societies; a virtual Exhibit Hall and Innovation Hub to showcase new technologies; and an immersive attendee experience in a virtual convention center.
